Brentuximab vedotin plus dacarbazine or nivolumab in classical Hodgkin lymphoma; loss of CD20 causes resistance to mosunetuzumab in r/r B-cell lymphomas; trogocytosis as a driver of RBC antigen loss
Blood Podcast
00:00
Exploring HDFN, AMIS, and Antigen Loss Through Antibodies in RBCs
Exploring the aloe-immune condition where maternal antibodies target fetal red blood cells, the symptoms it presents, and the prophylactic treatment using human polyclonal anti-RHD. Additionally, examining the link between antibodies inducing antigen loss and RBC clearance through experiments on mouse models and in vitro cultures.
Transcript
Play full episode
